32.jpg)
56.jpg)
ROSEMARY-EXTRACT COMPOSITIONS FOR TREATING CANCER
Patent number:
WO13060922
No items found.
The present invention relates to the use of a rosemary extract in the preparation of a composition for treating a cancer, in which there is a change in oestrogen signalling or lipid metabolism, to a composition comprising rosemary extract and a chemotherapeutic agent, and also to an in-vitro method for predicting the clinical response to an anti-tumour therapy using said composition.
Countries:
Spain
Regions:
Community of Madrid
Centers:
UNIVERSIDAD AUTONOMA DE MADRID, FUNDACION IMDEA ALIMENTACION
Other entities:
Sectors:
Health
Chemicals
Food & Agro
Subsectors:
Pharmaceuticals
TRL Level:
TRL 5 – technology validated in relevant environment (industrially relevant environment in the case of key enabling technologies)
BRL Level:
PDF Link:
Download hereVideo Link:
Watch it hereSustainable Development Goal:
SDG03: Good health and well-being
Applications
The present invention provides a new use of a rosemary extract in the treatment of certain cancers, specifically those in which there is an alteration in lipid metabolism or in the oestrogen signalling pathway. Furthermore, this composition can be combined with a conventional anti-tumour agent to obtain a synergistic effect.
Comments
Other related patents
New & Sustainable Materials
Chemicals
LIGHT-EMITTING ELECTROCHEMICAL CELLS BASED ON IONIC DYES
Health
MICROBIAL-BASED BIOHYBRID SYSTEM COMPRISING BIOGENIC SEMICONDUCTOR NANOPARTICLES AND A METHOD TO PRODUCE THE SAME
Health